ILAI for GLP-1 weight loss

The medicine turns your appetite down. ILAI makes every pound count.

Wegovy, Ozempic, Zepbound and Mounjaro do their part. How well they work depends on everything around them: enough protein when you are barely hungry, side effects noticed after each dose step, and labs read as the weight comes off. ILAI keeps all of it in view every day, so the progress you are paying for is progress you keep.

Reserve my spotSee how ILAI works →

ILAI opens November 15. Reserve your spot and your invitation to 14 free days arrives that morning. All it takes is your email: no account, no card, no charge.

Nutrition

Less appetite. Enough protein anyway.

On a GLP-1 you can get through half a day on a few bites, and protein is usually the first thing to fall short. Log a meal in a sentence or a photo, and ILAI shows what’s left against your protein floor while there’s still time to eat it.

  • Log the meal you actually ate. Type a few words or add a photo. Review ILAI’s estimate, then correct the portion or ingredients whenever you need to.
  • Keep your targets in view. See the targets in your record alongside today’s logged intake and activity.
  • Check the calculation. Open a target to see its inputs. If you set your own target, ILAI keeps both figures available to compare.

46 g protein logged · 125 g minimum · 79 g remainingSarah’s afternoon check-in

Source note: a 2025 joint advisory from four clinical societies on nutrition for people taking GLP-1 medications (AJCN).

A woman at her desk at lunch holds her phone over half a turkey and avocado wrap; the phone shows the lunch in Today’s log: half a wrap, the other half left, counted 245 kcal and 12 g protein, with what the meal did to her glucoseSarah’s 2 pm check on Oct 6: 5,584 steps, on pace; 701 kcal and 46 g protein so far from three meals, 79 g to the 125 g protein floor
Sarah’s 2 pm check: 46 g logged, 79 g still to go to her 125 g minimum, with dinner ahead.

Optional glucose connection

Your meals. Your glucose patterns.

Connect a compatible glucose sensor through Apple Health and the ILAI iPhone app. ILAI places available glucose readings beside the meals you log, helping you compare patterns across similar meals.

A sensor is optional. ILAI works without one.

A woman seen from behind in a sage tank top, a round white glucose sensor on the back of her upper arm, standing at a sunny kitchen counter with a bowl of yogurt and berries, a mug and a bowl of fruit
1Connect once. Keep logging meals.

Allow supported glucose readings through Apple Health. Use your sensor’s own app for current readings and alerts.

  1. A hand holding a phone at a wooden table beside a half-eaten turkey and avocado wrap with arugula and cherry tomatoes; the phone shows Today’s log for Sep 28: lunch at 12:29 pm, turkey and avocado wrap and baby carrots, 469 kcal and 31 g protein, and Glucose after this meal: rose 25 mg/dL from 88, peaked 1 h 36 min after she ate, back within 10 mg/dL of the start in 3 h 11 min, with the curve from 30 minutes before to 3 hours after
    2Look at the meal in context.

    Review the available curve around a meal, with timing and recorded activity alongside it.

3Compare patterns as records build.

Food groupings show the meals behind them. Early patterns remain labeled as early.

Turkey and avocado wrap · Median rise 25 mg/dL · 5 logged mealsSarah’s foods, by glucose response

Your sensor records the readings. ILAI brings the meals into view.

The rankings describe recorded glucose responses. They do not measure insulin or replace glucose alerts.

A hand holding a phone at a sunny kitchen counter beside a bowl of berries, a cup of yogurt, sliced whole-grain bread, apples, a banana and a bag of groceries; the phone shows ILAI’s “Your foods, by glucose response” from 36 clean meals: Steady, string cheese, protein bar, Greek yogurt with blueberries, cottage cheese with peach slices; Moderate, banana, sweet potato, quinoa; Sharp, turkey and avocado wrap, rose 25 mg/dL, median of 5 meals
Learn which of your own foods spike your glucose, and how many meals prove it.
Explore the glucose example

Sarah wears a CGM, a continuous glucose monitor about the size of a coin. A Stelo is sold over the counter in the US, no prescription needed; a Dexcom G7 works too. It writes her glucose to Apple Health, and ILAI reads it from there. She logs her meals as she always has.

Sep 28, 12:29 pm. She sees what her lunch did. Open the meal and it shows what her glucose did: up 25 mg/dL from 88, a peak 1 h 36 min after she ate, back near where it started at 3 h 11 min, and the curve from 30 minutes before to 3 hours after. Across the five times she logged this wrap, her glucose rose a median of 25 mg/dL and peaked about 1 h 40 min after lunch.

As the meals add up, patterns emerge. In her nutrition view, her foods start to sort into three groups. Steady: string cheese, Greek yogurt with blueberries, cottage cheese with peach slices. Moderate: banana, sweet potato, quinoa. Sharp: the wrap, whole-grain crackers, whole-grain toast. Each food shows how many of her meals it rests on, and one marked early has only two or three behind it. The groups come from her own meals, as she usually eats them, not a chart for everyone, and they keep updating as she logs more.

What she can do with it.

  • Same craving, a better version. If toast moves you and Greek yogurt doesn’t, you keep breakfast and pick the steadier one. Often it’s a small swap: protein first, carbs last, a different bread.
  • Something real to bring your prescriber. Weeks of your own meals and how your glucose answered, next to your A1c.
  • Answers for your body, not an average one. Two people eating the same food can respond very differently (Weizmann Institute, Cell, 2015).

Every meal you log shows me how your body handles it, and the picture sharpens as you log more. Early groups are marked as early.

  1. Today’s log, lunch at 12:30 pm on Oct 8: grilled salmon, jasmine rice, broccoli and cooking oil, 588 kcal and 39 g protein. Glucose after this meal: rose 24 mg/dL from 87, peaked 1 h 40 min after, back within 10 mg/dL of the start in 3 h 40 min; under the curve: A walk 40 min after may have lowered this
    Oct 8. A walk after lunch stays out of her rankings.

    She set out on a walk 40 minutes after a lunch of salmon and rice. ILAI shows the rise and says what else happened: “A walk 40 min after may have lowered this.” It keeps the walk beside the meal rather than crediting either one, and leaves that meal out of her food ranking.

Symptoms & context

Queasy since the dose went up? Now you can show it.

Log a symptom and rate it in a few taps. ILAI dates it against your last dose step, your meals and your sleep, so “it started four days after I went to 0.5 mg” is on the page, not just in your memory.

  • Capture it while it is fresh. Choose a symptom, rate its severity and add a note.
  • Put the timing together. Review symptoms alongside recorded medication changes and available sleep and activity data.
  • Bring a clearer account. Add the entries you want to discuss to your appointment summary.

Timing can raise a useful question. It does not establish a cause. If you need medical help, do not wait for an ILAI brief.

“Nausea logged 2 of the last 3 days. Has it affected how much you can drink? Keep fluids going through the day; your doctor should hear about persistent nausea or trouble keeping fluids down.”ILAI, the evening recap
Michael’s semaglutide plan on the ILAI timeline on his phone: the dose drawn as a step from 0.25 mg to 0.5 mg on Sep 28, his logged symptoms as dots beneath it, and the one from Oct 2 open: nausea, 3 of 10, in his words “Queasy the mornings since the higher dose. Settles by lunch, no vomiting,” with the line “4 days after semaglutide went from 0.25 to 0.5 mg (Sep 28)”
An Apple Watch on a wrist on green marble showing an ILAI notification: “Midday check. 6,120 steps so far, on pace for 8,000 · 50 g to your protein floor”
When a side effect follows a dose change, you see the two side by side, before your next appointment.

Progress over time

More than a number on the scale.

When weight comes off fast, you want it to be fat, not muscle. Put your weight trend, body-composition scans and photo check-ins side by side, and see what the scale alone can’t tell you.

  1. Weight trends Compare readings over time rather than relying on a single day.
  2. Body-composition reports Add supported reports and compare dated measurements.
  3. Photo check-ins Use consistent poses, lighting and framing to make visual comparisons more useful.
  • One review, several perspectives. Bring the records you choose into your appointment summary.
Compare on the phone: the front-relaxed pose from June 4 and September 4, 2026 under one divider, 25% body fat then 20%; pose buttons front relaxed, front flexed, left side and back; comparing with the one beforeA second check-in compared: the front-relaxed pose from Apr 27 and May 6, 2026 under one divider, 177.6 lb and 18.3% body fat on both dates
Photos show appearance. Body-composition values carry the source that measured them.

Before you step up a dose, know where you stand.

Thinking about the next titration step? ILAI shows how the last one went: the side effects, the protein you managed, your weight trend and any lab that moved. You and your prescriber decide on evidence.

  • What changed? Recent entries and their dates.
  • What else was happening? Other changes in the record.
  • What needs discussing? Questions linked to that history.

ILAI does not prescribe or change doses.

Keep the next conversation connected. If your prescriber’s practice uses ILAI, send your question with the relevant record. Otherwise, prepare a summary to share through their portal or at your appointment.

A woman at a kitchen table, a medication pen beside her hand, reads ILAI’s answer on her phone after asking about her next dose: what to raise with her prescriber before any change
Before a dose step, ask first: the answer comes from your own record.

Coverage documentation

Insurer asking for proof? It’s already written.

GLP-1 coverage often depends on records: doses taken, weight over time, and the labs on record. ILAI keeps them dated as you go, so the summary your prescriber needs is ready when they ask.

  • Print or save the available summary. Your prescriber can decide what belongs in the request; requirements differ by insurer and plan.
  • ILAI does not submit claims or guarantee coverage.
Coverage summary for Alex Morgan, prepared Oct 9, 2026 from the record in ILAI, for the prescriber: Medication, tirzepatide 2.5 mg once a week started Mar 9, 2026, doses recorded taken 29 of 30 scheduled (97%); Weight, 183.7 lb on Mar 16, 2026 to 180.2 lb on Oct 8, 2026, a change of 3.5 lb or 1.9%, BMI 27.9 to 27.4 from a height of 68 in and 63 scale readings; Labs, before and latest with reference ranges: HbA1c 5.2% on Jun 6, 2024 from Ulta Lab Tests / Quest, reference 5.7; fasting glucose 88 mg/dL on Feb 18, 2026, reference 65 to 99
Proof for your prescriber in one page: doses taken, weight with dates, and the labs on record.

Ready for what’s next

A new medicine. The same record.

Retatrutide, Eli Lilly’s investigational medicine that acts on three hormone receptors (GIP, GLP-1 and glucagon), is in late-stage trials and not yet approved by the FDA. If it is approved and your prescriber chooses it, ILAI is ready from day one. Every titration step goes on your timeline, each side effect is dated against it, and your labs are read straight across the switch from the medicine you take now.

Reserve my spot

ILAI opens November 15. Reserve your spot and your invitation to 14 free days arrives that morning. All it takes is your email: no account, no card, no charge.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Retatrutide is an investigational medicine developed by Eli Lilly and Company and is not approved by the FDA. ILAI Health, Inc. is not affiliated with Novo Nordisk or Eli Lilly and Company.